PHVS
Pharvaris BV
NASDAQ: PHVS · HEALTHCARE · BIOTECHNOLOGY
$30.09
+1.38% today
Updated 2026-05-08
Market cap
$1.97B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.48
Dividend yield
—
52W range
$15 – $31
Volume
0.3M
Pharvaris BV (PHVS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.92M | $-6.68M | $-21.50M | $-44.60M | $-67.16M | $-93.05M | $-120.13M | $-137.07M |
| Capital expenditures | $13476.00 | $13476.00 | $42977.00 | $130032.00 | $124296.00 | $89984.00 | $538086.00 | $164619.00 |
| Depreciation | $549.00 | $549.00 | $7401.00 | $77370.00 | $152941.00 | $257551.00 | $269562.00 | — |
| Stock-based comp | $100745.00 | $116147.00 | $1.59M | $8.20M | $11.35M | $10.66M | $16.21M | $19.05M |
| Free cash flow | $-3.93M | $-6.69M | $-21.54M | $-44.73M | $-67.29M | $-93.14M | $-120.67M | $-137.24M |
| Investing cash flow | $-13476.00 | $-13476.00 | $-42977.00 | $-130032.00 | $-124296.00 | $-89984.00 | $-538086.00 | — |
| Financing cash flow | $4.51M | $21.63M | $101.20M | $143.67M | $8.65M | $325.39M | $2.68M | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |